All Things Investigations – Navigating Secondary Tariffs with Mike Huneke and Brent Carlson
FCPA Compliance Report: The Impact of Secondary Tariffs on Global Trade with Mike Huneke and Brent Carlson
10 For 10: Top Compliance Stories For the Week Ending June 14, 2025
Daily Compliance News: June 9, 2025, The Repugnant Edition
Compliance in the Former Soviet Central Asian Republics
Episode 330 – Halyna Senyk on Anti-Corruption Progress in Ukraine
FINCast Ep. 39 – State of Russia Sanctions Two Years After the Invasion
Season 2 Episode 4 - Russia Enforcement and the involvement of DOJ's Task Force KleptoCapture
The Justice Insiders Podcast: The Latest on Russia Sanctions and the Enhanced Enforcement Environment
Episode 271 -- Deep Dive into Microsoft's OFAC Settlement for $3 Million
The New Cold War: Risk, Sanctions, Compliance Episode 27: “The Yukos Case: 20 Years Later”
The New Cold War: Risk, Sanctions, Compliance Episode 26: “International Sports: Politics, Corruption, Doping and Compliance”
The New Cold War: Risk, Sanctions, Compliance Episode 25: “Can the U.S. Seize the Russian Central Bank’s Assets?”
The New Cold War: Risk, Sanctions, Compliance Episode 23: "Former FBI Acting Director Andrew McCabe”
The New Cold War: Risk, Sanctions, Compliance Episode 20: "Rich Russians: From Oligarchs to Bourgeoisie"
The New Cold War: Risk, Sanctions, Compliance Episode 19: “Psychological Profiling, Crisis Management, and the New Cold War”
Compliance in Ukraine
FINCast Ep. 34 - A Storied Journey in the World of Financial Integrity: A Conversation with Stuart Levey
Putin's Oil Heist - Episode 5: Fighting From Afar
FCPA Compliance Report - Josh Fitzhugh on Trade Compliance Since the Russian Invasion of Ukraine
Russia’s full-scale invasion of Ukraine is now in its third year, and we continue to see unprecedented levels of activity and instability with public clashes between world leaders, trade wars, and critical foreign aid cuts by...more
This regular alert covers key policy and regulatory developments related to EU geopolitical risks, including in particular, economic security, Russia’s war against Ukraine, health threats, and cyber threats. It does not...more
On March 2, 2022, the Office of Foreign Assets Control ("OFAC") of the U.S. Department of the Treasury issued General License No. 13, which authorized "U.S. persons . . . to pay taxes, fees, or import duties, and purchase or...more
In an open letter posted on February 26, six life sciences business leaders called on other members of their industry "to cease all business involvement in Russia." The authors of the open letter included Meg Alexander,...more
There are two parallel sanctions processes unfolding in Washington, D.C. – one from the Biden administration and the other from the U.S. Congress. Regardless of what approach the government takes, we do not expect the life...more
On March 1, 2021, the Eurasian Patent Office (EAPO) launched the EAPO Pharmaceutical Register (the 'Register'). The Register lists Eurasian patents that relate to the active pharmaceutical ingredients of the drugs according...more
In Washington: The Senate passed the $1.9 trillion pandemic relief package in a 50-49 party-line vote. The Senate is sending an amended version of the American Recovery Plan back to the House with some changes. The House is...more
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology...more
Having vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable patents disputes in Life...more
The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. ...more
Last week, authorities from the United States, United Kingdom and Canada accused a well-known hacker group tied to the Russian government, APT29 a/k/a Cozy Bear of using malware to exploit security vulnerabilities to enable...more
This summary is intended to help clients navigate the large number of legal measures taken expeditiously by the Russian authorities in connection with the spread of COVID-19. The summary is not exhaustive. It includes only...more
Last month, the Russian government passed a decree (the Decree) amending the rules on state regulation of ceiling prices for drugs included in the Vital and Essential Drugs List (Essential Drugs), which is approved annually....more
Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical licence....more
Led by partner Natalia Gulyaeva, the Hogan Lovells Moscow team represented Novartis in a precedent case for pharma business proving that one can obtain an injunction using patent rights against a generic in Russia before the...more
U.S.-based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions. In this series, members of our European Life Sciences Transactions...more